C.M. Bidwell & Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104K Hold
1,981
0.04% 173
2026
Q1
$70K Sell
1,981
-649
-25% -$20.1K 0.03% 196
2025
Q4
$73.6K Buy
+2,630
New +$78.8K 0.03% 210
2024
Q2
Sell
-1,375
Closed -$37.2K 480
2024
Q1
$37.2K Buy
1,375
+50
+4% +$1.42K 0.03% 242
2023
Q4
$36.8K Hold
1,325
0.03% 239
2023
Q3
$37.1K Buy
+1,325
New +$38.8K 0.03% 303

Other funds holding ALKS

C.M. Bidwell & Associates's ALKS Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Alkermes (ALKS) position steady in Q2 2026 at 1,981 shares worth $104K. The position accounts for 0.04% of the portfolio, ranked #173.

C.M. Bidwell & Associates first reported a position in ALKS in Q3 2023 and has held it in 6 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • C.M. Bidwell & Associates held 1,981 shares of Alkermes worth $104K as of Q2 2026.
  • C.M. Bidwell & Associates left its Alkermes share count unchanged in Q2 2026.
  • Alkermes made up 0.04% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #173 holding.
  • C.M. Bidwell & Associates first reported a position in Alkermes in Q3 2023 and has held it in 6 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.